Ibnsina Pharma (CASE: ISPH)
Health Care · Health Care Providers & Services · EG
EGP13.02
-3.91% today · +21.6% 1Y
Ibnsina Pharma (CASE: ISPH) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $257.95M.
Over the last twelve months the share price has gained 21.6%, trading between 9.63 and 16.93.
Tweenvest scores Ibnsina Pharma across four factors: quality 49/100, value 51/100, growth 94/100, dividend 65/100. Its strongest factor is growth.
ISPH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $257.95M
- Revenue (TTM)
- $1.69B
- P/E
- 15.08
- EPS
- 0.86
- Dividend yield
- 1.23%
- Beta (5Y)
- 0.72
- 52-week high
- EGP16.93
- 52-week low
- EGP9.63
- Avg volume (3M)
- —
- Shares outstanding
- 1.01B
- Employees
- —
- Next earnings
- —
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $350.16B | $390.11 | +1.37% |
| CVS Health CorporationNYSE: CVS | $118.97B | $93.02 | -0.67% |
| McKesson CorporationNYSE: MCK | $100.14B | $858.90 | +2.40% |
| HCA Healthcare, Inc.NYSE: HCA | $92.92B | $429.19 | +5.64% |
| Elevance Health, Inc.NYSE: ELV | $86.86B | $400.54 | +1.07% |
| The Cigna GroupNYSE: CI | $73.33B | $277.51 | +1.13% |
| Cencora, Inc.NYSE: COR | $60.69B | $318.04 | +1.06% |
| Cardinal Health, Inc.NYSE: CAH | $53.38B | $229.51 | +0.46% |
Figures last refreshed Aug 18, 2026.